8-ethyl-4-(3-nitrobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3,5-Dimethylcyclohexanol (mixture of isomers)>98.0%(GC)500mL

Cyclohexyl Vinyl Ether (stabilized with KOH)>98.0%(GC)500mL

(R)-tert-Butyl (2-amino-1-phenylethyl)carbamate, 95%, 1g

2-(dimethylamino)-1,3,8-triazaspiro[4.5]dec-1-en-4-one dihydrochloride hydrate, 95.0%, 250mg

3-[(3,5-dimethylphenyl)amino]propanoic acid, 97%, 100mg

(4-(4-Methylthiazol-5-yl)phenyl)methanamine hydrochloride, 97%, 5g

(2S,4S)-4-Fluoropyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 10g

3-Bromo-1H-pyrrolo[3,2-b]pyridine, 95.0%, 10g

2-Amino-5-sulfobenzoic acid, 95.0%, 25g

D-cysteine hydrochloride hydrate, 95.0%, 1g

1-Boc-4-(piperidin-4-yl)-piperazine, 98.0%, 1g

6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-b]pyridine, 95%, 1g